The pharmaceutical and biotech industries have seen an increase in the number and species of bacterial endospores and mold spores found in their facilities. This presentation will focus on ways to limit bacterial and mold spore contamination from incoming items into pharmaceutical and biotech operations and limit other sources of spore contamination. Sporicidal products will be discussed and data will be presented which can be used to address bacterial spore issues. Current industry regulation in the US and Europe will be discussed related to sporicides. Additionally, the presentation will convey a robust approach to addressing bacterial spores by covering personnel practices, incoming items into operations, facility design and conditions, and the products used to address bacterial and mold spores as well as more resistant bacterial spore species.
For more information or to register, visit the PDA Texas Chapter's website here.